These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34062871)

  • 1. Infection Prevention and Control at Lira University Hospital, Uganda: More Needs to Be Done.
    Opollo MS; Otim TC; Kizito W; Thekkur P; Kumar AMV; Kitutu FE; Kisame R; Zolfo M
    Trop Med Infect Dis; 2021 May; 6(2):. PubMed ID: 34062871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infection Prevention and Control in Three Tertiary Healthcare Facilities in Freetown, Sierra Leone during the COVID-19 Pandemic: More Needs to Be Done!
    Kamara IF; Tengbe SM; Fofanah BD; Bunn JE; Njuguna CK; Kallon C; Kumar AMV
    Int J Environ Res Public Health; 2022 Apr; 19(9):. PubMed ID: 35564669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infection prevention and control in tertiary care hospitals of Bangladesh: results from WHO infection prevention and control assessment framework (IPCAF).
    Harun MGD; Anwar MMU; Sumon SA; Hassan MZ; Haque T; Mah-E-Muneer S; Rahman A; Abdullah SAHM; Islam MS; Styczynski AR; Kaydos-Daniels SC
    Antimicrob Resist Infect Control; 2022 Oct; 11(1):125. PubMed ID: 36203207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An assessment of infection prevention and control implementation in Malawian hospitals using the WHO Infection Prevention and Control Assessment Framework (IPCAF) tool.
    Ng'ambi D; O'Byrne T; Jingini E; Chadwala H; Musopole O; Kamchedzera W; Tancred T; Feasey N
    Infect Prev Pract; 2024 Dec; 6(4):100388. PubMed ID: 39286836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement in Infection Prevention and Control Compliance at the Three Tertiary Hospitals of Sierra Leone following an Operational Research Study.
    Kamara RZ; Kamara IF; Moses F; Kanu JS; Kallon C; Kabba M; Moffett DB; Fofanah BD; Margao S; Kamara MN; Moiwo MM; Kpagoi SSTK; Tweya HM; Kumar AMV; Terry RF
    Trop Med Infect Dis; 2023 Jul; 8(7):. PubMed ID: 37505674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating infection prevention and control programs in Austrian acute care hospitals using the WHO Infection Prevention and Control Assessment Framework.
    Aghdassi SJS; Grisold A; Wechsler-Fördös A; Hansen S; Bischoff P; Behnke M; Gastmeier P
    Antimicrob Resist Infect Control; 2020 Jun; 9(1):92. PubMed ID: 32571434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A national survey on the implementation of key infection prevention and control structures in German hospitals: results from 736 hospitals conducting the WHO Infection Prevention and Control Assessment Framework (IPCAF).
    Aghdassi SJS; Hansen S; Bischoff P; Behnke M; Gastmeier P
    Antimicrob Resist Infect Control; 2019; 8():73. PubMed ID: 31080588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infection prevention and control in Indonesian hospitals: identification of strengths, gaps, and challenges.
    Supriadi IR; Haanappel CP; Saptawati L; Widodo NH; Sitohang G; Usman Y; Anom IB; Saraswati RD; Heger M; Doevendans PA; Satari HI; Voor In 't Holt AF; Severin JA
    Antimicrob Resist Infect Control; 2023 Feb; 12(1):6. PubMed ID: 36732802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing infection prevention and control structures in German hospitals after the COVID-19 pandemic using the WHO infection prevention and control assessment framework (IPCAF): results from 660 hospitals and comparison with a pre-pandemic survey.
    Rüther FD; Gropmann A; Hansen S; Behnke M; Geffers C; Aghdassi SJS
    Antimicrob Resist Infect Control; 2024 Sep; 13(1):103. PubMed ID: 39272204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A nationwide survey on the implementation of infection prevention and control components in 1442 hospitals in the Republic of Korea: comparison to the WHO Infection Prevention and Control Assessment Framework (IPCAF).
    Jeong Y; Joo H; Bahk H; Koo H; Lee H; Kim K
    Antimicrob Resist Infect Control; 2022 May; 11(1):71. PubMed ID: 35562838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The first WHO global survey on infection prevention and control in health-care facilities.
    Tomczyk S; Twyman A; de Kraker MEA; Coutinho Rehse AP; Tartari E; Toledo JP; Cassini A; Pittet D; Allegranzi B
    Lancet Infect Dis; 2022 Jun; 22(6):845-856. PubMed ID: 35202599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testing of the WHO Infection Prevention and Control Assessment Framework at acute healthcare facility level.
    Tomczyk S; Aghdassi S; Storr J; Hansen S; Stewardson AJ; Bischoff P; Gastmeier P; Allegranzi B
    J Hosp Infect; 2020 May; 105(1):83-90. PubMed ID: 31870887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of Infection Prevention and Control (IPC) Implementation and Strategies Used for IPC Preparedness at Facility Level in Underdeveloped Areas of Pakistan.
    Tahir MA; Khan MA; Ikram A; Chaudhry TH; Jabeen A; Quddous A; Haq IU
    Infect Drug Resist; 2023; 16():1997-2006. PubMed ID: 37038477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline evaluation of the World Health Organization (WHO) infection prevention and control (IPC) core components in Pacific Island Countries and Territories (PICTs).
    Leong M; Picton R; Wratten M; Mahe A; Zimmerman PA
    Antimicrob Resist Infect Control; 2024 Sep; 13(1):108. PubMed ID: 39334478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First nationwide survey of infection prevention and control among healthcare facilities in Japan: impact of the national regulatory system.
    Nomoto H; Saito H; Ishikane M; Gu Y; Ohmagari N; Pittet D; Kunishima H; Allegranzi B; Yoshida M
    Antimicrob Resist Infect Control; 2022 Nov; 11(1):135. PubMed ID: 36352429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of Infection Prevention and Control Measures at Points of Entry in Sierra Leone in 2021: A Cross-Sectional Study.
    Kamara KN; Squire JS; Kanu JS; Carshon-Marsh R; Koroma Z; Koroma AT; Maruta A; Kallon C; Manzi M; Camara BS; Sargsyan A; Delamou A; Guth JA; Reid A; Khogali MA; Vandi MA
    Int J Environ Res Public Health; 2022 May; 19(10):. PubMed ID: 35627473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of the infection prevention and control core components at the national level: a global situational analysis.
    Tartari E; Tomczyk S; Pires D; Zayed B; Coutinho Rehse AP; Kariyo P; Stempliuk V; Zingg W; Pittet D; Allegranzi B
    J Hosp Infect; 2021 Feb; 108():94-103. PubMed ID: 33271215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuberculosis infection prevention and control in rural Papua New Guinea: an evaluation using the infection prevention and control assessment framework.
    Marme G; Kuzma J; Zimmerman PA; Harris N; Rutherford S
    Antimicrob Resist Infect Control; 2023 Apr; 12(1):31. PubMed ID: 37046339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Status of infection prevention and control (IPC) as per the WHO standardised Infection Prevention and Control Assessment Framework (IPCAF) tool: existing evidence and its implication.
    Asgedom AA
    Infect Prev Pract; 2024 Jun; 6(2):100351. PubMed ID: 38469414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of the WHO core components of an infection prevention and control programme in two sub-saharan African acute health-care facilities: a mixed methods study.
    Wood R; Tembele W; Hema A; Somé A; Kinganda-Lusamaki E; Basilubo C; Lumembe R; Alama N; Mbunsu G; Zongo A; Ahuka S; Muyembe JJ; Leendertz F; Eckmanns T; Schubert G; Kagoné T; Makiala S; Tomczyk S
    Antimicrob Resist Infect Control; 2024 Jan; 13(1):4. PubMed ID: 38221629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.